499 related articles for article (PubMed ID: 35740453)
1. Molecular Pathophysiological Mechanisms in Huntington's Disease.
Jurcau A
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740453
[TBL] [Abstract][Full Text] [Related]
2. From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research.
Jiang A; Handley RR; Lehnert K; Snell RG
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629202
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Strategies in Huntington's Disease: From Genetic Defect to Gene Therapy.
Jurcau A; Jurcau MC
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009443
[TBL] [Abstract][Full Text] [Related]
4. Huntington's disease: pathogenesis to animal models.
Kumar P; Kalonia H; Kumar A
Pharmacol Rep; 2010; 62(1):1-14. PubMed ID: 20360611
[TBL] [Abstract][Full Text] [Related]
5. Reactive astrocytes promote proteostasis in Huntington's disease through the JAK2-STAT3 pathway.
Abjean L; Ben Haim L; Riquelme-Perez M; Gipchtein P; Derbois C; Palomares MA; Petit F; Hérard AS; Gaillard MC; Guillermier M; Gaudin-Guérif M; Aurégan G; Sagar N; Héry C; Dufour N; Robil N; Kabani M; Melki R; De la Grange P; Bemelmans AP; Bonvento G; Deleuze JF; Hantraye P; Flament J; Bonnet E; Brohard S; Olaso R; Brouillet E; Carrillo-de Sauvage MA; Escartin C
Brain; 2023 Jan; 146(1):149-166. PubMed ID: 35298632
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
7. Selective neuronal degeneration in Huntington's disease.
Cowan CM; Raymond LA
Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dynamics and quality control in Huntington's disease.
Guedes-Dias P; Pinho BR; Soares TR; de Proença J; Duchen MR; Oliveira JM
Neurobiol Dis; 2016 Jun; 90():51-7. PubMed ID: 26388396
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments.
Roze E; Saudou F; Caboche J
Curr Opin Neurol; 2008 Aug; 21(4):497-503. PubMed ID: 18607213
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of G-protein coupled receptors in Huntington's disease.
Dowie MJ; Scotter EL; Molinari E; Glass M
Pharmacol Ther; 2010 Nov; 128(2):305-23. PubMed ID: 20708032
[TBL] [Abstract][Full Text] [Related]
11. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
Kacher R; Lamazière A; Heck N; Kappes V; Mounier C; Despres G; Dembitskaya Y; Perrin E; Christaller W; Sasidharan Nair S; Messent V; Cartier N; Vanhoutte P; Venance L; Saudou F; Néri C; Caboche J; Betuing S
Brain; 2019 Aug; 142(8):2432-2450. PubMed ID: 31286142
[TBL] [Abstract][Full Text] [Related]
12. In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons.
Thomas EA; Coppola G; Tang B; Kuhn A; Kim S; Geschwind DH; Brown TB; Luthi-Carter R; Ehrlich ME
Hum Mol Genet; 2011 Mar; 20(6):1049-60. PubMed ID: 21177255
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.
Tabrizi SJ; Workman J; Hart PE; Mangiarini L; Mahal A; Bates G; Cooper JM; Schapira AH
Ann Neurol; 2000 Jan; 47(1):80-6. PubMed ID: 10632104
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
Canals JM; Pineda JR; Torres-Peraza JF; Bosch M; Martín-Ibañez R; Muñoz MT; Mengod G; Ernfors P; Alberch J
J Neurosci; 2004 Sep; 24(35):7727-39. PubMed ID: 15342740
[TBL] [Abstract][Full Text] [Related]
15. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
[TBL] [Abstract][Full Text] [Related]
16. Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction.
Weiss A; Roscic A; Paganetti P
Mol Neurodegener; 2009 Feb; 4():11. PubMed ID: 19203385
[TBL] [Abstract][Full Text] [Related]
17. The selective vulnerability of nerve cells in Huntington's disease.
Sieradzan KA; Mann DM
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
[TBL] [Abstract][Full Text] [Related]
18. Huntington's disease: progress and potential in the field.
Stack EC; Ferrante RJ
Expert Opin Investig Drugs; 2007 Dec; 16(12):1933-53. PubMed ID: 18042002
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
Bithell A; Johnson R; Buckley NJ
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
[TBL] [Abstract][Full Text] [Related]
20. Huntington's disease: pathomechanism and therapeutic perspectives.
Gárdián G; Vécsei L
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1485-94. PubMed ID: 15480847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
